Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
The Globe and Mail8h
Canadian ETF Comparison Series: ZQQ, XQQ, and QQC.F
For Canadian investors, the BMO NASDAQ 100 Equity Hedged to CAD ETF (Ticker ZQQ) and iShares NASDAQ 100 ETF (CAD-Hedged) (Ticker: XQQ) are two of the larger Canadian-listed ETFs that replicate QQQ’s ...
Promising Clinical Progress and Financial Stability Drive Buy Rating for IO Biotech
TD Cowen analyst Yaron Werber has maintained their bullish stance on IOBT stock, giving a Buy rating yesterday. Yaron Werber has given his Buy ...